<DOC>
	<DOCNO>NCT01797055</DOCNO>
	<brief_summary>Atransferrinemia rare disorder , cause deficiency protein transferrin . No regular treatment available patient . The objective study investigate pharmacokinetics , efficacy safety Apotransferrin replacement therapy atransferrinemia patient .</brief_summary>
	<brief_title>Apotransferrin Atransferrinemia</brief_title>
	<detailed_description />
	<mesh_term>Metal Metabolism , Inborn Errors</mesh_term>
	<criteria>Established diagnosis atransferrinemia , define serum level transferrin 40 mg/dl Informed consent Known allergic reaction human plasma plasma product Having detectable antiimmunoglobulin A antibody</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>transferrin</keyword>
	<keyword>anemia</keyword>
	<keyword>iron overload</keyword>
</DOC>